Sfoglia per Autore
Raf-1 Kinase Inhibitor Protein down-regulation in hepatocellular carcinoma: investigation of possible mechanisms
2012-01-01 Labbozzetta, M; Poma, P; Vivona, N; D'Alessandro, N; NOTARBARTOLO DI VILLAROSA, M
Analysis of Possible Mechanisms Accounting for Raf-1 Kinase Inhibitor Protein Downregulation in Hepatocellular Carcinoma
2012-01-01 Poma, P; Labbozzetta, M; Vivona, N; Porcasi, R; D'Alessandro, N; Notarbartolo Di Villarosa, M
Analysis of UGT1A1*28 and DPYD*2A polymorphisms in Sicilians patients with metastatic colorectal cancer treated with Irinotecan and 5-fluorouracil.
2013-01-01 Labbozzetta, M; Vivona, N; Poma, P; Notarbartolo Di Villarosa, M; D'Alessandro, N
Analysis of pharmacologic approaches able to restore RKIP function in hepatocellular carcinoma
2013-01-01 Poma, P; Notarbartolo Di Villarosa, M; Labbozzetta, M; Vivona, N; D'Alessandro, N
Mechanisms of Raf-1 Kinase Inhibitor Protein Dysregulation in Triple-Negative Breast Cancers and Identification of Possible Novel Therapeutic Approaches for These Tumors
2014-01-01 D'Alessandro, N; Poma, P; Labbozzetta, M; Vivona, N; NOTARBARTOLO DI VILLAROSA, M
NF-κB is a potential pharmacological target in triple negative breast cancers.
2015-01-01 Labbozzetta, M; Poma, P; Vivona, N; D’Alessandro, N; NOTARBARTOLO DI VILLAROSA, M
Epigenetic changes and nuclear factor-κB activation, but not microRNA-224, downregulate Raf-1 kinase inhibitor protein in triple‑negative breast cancer SUM 159 cells
2015-01-01 Labbozzetta, M; Poma, P; Vivona, N; Gulino, A; D'Alessandro, N; NOTARBARTOLO DI VILLAROSA, M
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile